Uncover key drivers, emerging technologies, and competitive movements shaping the somatic genetic testing market from 2025–2034 with trusted insights from The Business Research Company

How Is The Somatic Genetic Testing Market Expected To Grow In Terms Of Size?

The somatic genetic testing market size has seen rapid expansion in recent years. It is anticipated to increase from $6.81 billion in 2024 to $7.78 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.3%. This historical growth can be linked to heightened awareness of genetic ailments, a rise in cancer instances, increasing integration of genetic testing in medical facilities, development of healthcare infrastructure, and surging patient requests for customized therapies.

The somatic genetic testing market size is anticipated to experience substantial growth in the upcoming years, with projections indicating an increase to $13.13 billion by 2029, at a compound annual growth rate (CAGR) of 14.0%. This expansion during the forecast period is primarily driven by an increasing focus on early disease identification, burgeoning collaborations between biotech and pharmaceutical companies, the development of more public-private partnerships, and the wider availability of diagnostic instruments. Noteworthy trends expected over this period include advancements in sequencing technology, innovations within bioinformatics and artificial intelligence, increased investment in research and development, the emergence of non-invasive testing methodologies, and breakthroughs in next-generation sequencing platforms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

What Market Forces Are Contributing To The Growth Of The Somatic Genetic Testing Market?

The rising occurrence of cancer is projected to fuel the expansion of the somatic genetic testing market moving ahead. Cancer describes a range of illnesses defined by the unchecked proliferation and dissemination of atypical cells throughout the body. This growing burden of cancer stems from lifestyle factors like an unhealthy diet, tobacco use, lack of physical activity, and heavy alcohol intake. Somatic genetic testing assists in identifying cancer by pinpointing genetic mutations specific to tumors, thereby facilitating precise and individualized treatment strategies. This testing reduces the need for invasive procedures through the application of advanced technologies, enhancing the precision of diagnosis and improving results for patients. For example, in July 2024, data from the Australian Institute of Health and Welfare, a government agency located in Australia, indicated that the count of cancer cases diagnosed in Australia totaled 160,570 in 2022, signifying an uptick of 3,789 cases from the 156,781 recorded in 2021. Consequently, the escalating occurrence of cancer is a key factor propelling the expansion of the somatic genetic testing market.

How Is The Somatic Genetic Testing Market Segmented Across Key Categories?

The somatic genetic testing market covered in this report is segmented

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Carrier Screening, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Inherited Genetic Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, At-Home Testing Providers, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Carrier Screening: Expanded Carrier Screening, Ethnicity-Based Carrier Screening, Universal Carrier Screening

5) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

What Key Trends Are Driving Growth In The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are focusing on developing advanced diagnostic solutions, such as liquid biopsy tests, to improve accuracy, enable early detection, and reduce the need for invasive procedures. These liquid biopsy tests involve non-invasive methods that analyze circulating tumor DNA (ctDNA) or other biomarkers in blood samples to detect cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test. This next-generation liquid biopsy test is designed to detect circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test created to identify somatic mutations across 74 key cancer-related genes. This test assists in personalized cancer treatment by identifying actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without requiring traditional tissue biopsies. It supports precision oncology, helping to guide targeted therapies and monitor disease progression or resistance in real-time.

Who Are The Major Stakeholders Operating In The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

How Do Regional Dynamics Influence The Somatic Genetic Testing Market Performance?

North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2025, By The Business Research Company

Smart Workplace Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Smart Windows Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Cloud Office Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cloud-office-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model